Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Hocking

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Investigative Dermatology|June 2, 2015
Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort StudyRavi F Sood, Anne M Hocking, Lara A Muffley, et al.
The Journal of Clinical Investigation|February 2, 2021
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severityHamid Bolouri, Cate Speake, David Skibinski, et al.
Plos One|September 30, 2015
Race Does Not Predict Melanocyte Heterogeneous Responses to Dermal Fibroblast-Derived MediatorsPornthep Sirimahachaiyakul, Ravi F Sood, Lara A Muffley, et al.
Frontiers in Immunology|August 1, 2022
IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune DysregulationKatharina Lambert, Kirsten E Diggins, Britta E Jones, et al.
Diabetes|March 22, 2019
Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D ProgressionTania Habib, S Alice Long, Peter L Samuels, et al.
Plos One|May 3, 2011
Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarringLoren H Engrav, Christopher K Tuggle, Kathleen F Kerr, et al.
JCI Insight|October 25, 2022
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell functionCate Speake, Tania Habib, Katharina Lambert, et al.
Frontiers in Immunology|April 23, 2024
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk allelesSarah Alice Long, Virginia S Muir, Britta E Jones, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Investigative Dermatology|June 2, 2015
Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort StudyRavi F Sood, Anne M Hocking, Lara A Muffley, et al.
The Journal of Clinical Investigation|February 2, 2021
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severityHamid Bolouri, Cate Speake, David Skibinski, et al.
Plos One|September 30, 2015
Race Does Not Predict Melanocyte Heterogeneous Responses to Dermal Fibroblast-Derived MediatorsPornthep Sirimahachaiyakul, Ravi F Sood, Lara A Muffley, et al.
Frontiers in Immunology|August 1, 2022
IL-6-Driven pSTAT1 Response Is Linked to T Cell Features Implicated in Early Immune DysregulationKatharina Lambert, Kirsten E Diggins, Britta E Jones, et al.
Diabetes|March 22, 2019
Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D ProgressionTania Habib, S Alice Long, Peter L Samuels, et al.
Plos One|May 3, 2011
Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarringLoren H Engrav, Christopher K Tuggle, Kathleen F Kerr, et al.
JCI Insight|October 25, 2022
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell functionCate Speake, Tania Habib, Katharina Lambert, et al.
Frontiers in Immunology|April 23, 2024
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk allelesSarah Alice Long, Virginia S Muir, Britta E Jones, et al.
Pageof 3